-
公开(公告)号:NO780388A
公开(公告)日:1978-08-08
申请号:NO780388
申请日:1978-02-03
Applicant: BASF AG
Inventor: FRICKEL FRITZ-FRIEDER , HAGEN HELMUT , OHNSORGE ULRICH , FRANKE ALBRECHT , LENKE DIETER , GRIES JOSEF , LEHMANN HANS DIETER
IPC: A61K31/428 , C07D275/04 , C07D
CPC classification number: C07D275/04
-
公开(公告)号:DK164699C
公开(公告)日:1992-12-21
申请号:DK416082
申请日:1982-09-17
Applicant: BASF AG
Inventor: FRANKE ALBRECHT , MUELLER JOSEF , LIETZ HELMUT , WIERSDORFF WALTER-WIELANT , HEGE HANS-GUENTHER , MUELLER CLAUS D , GRIES JOSEF , LENKE DIETER , PHILIPSBORN GERDA VON , RASCHACK MANFRED
IPC: A61K31/13 , A61K31/445 , A61K31/495 , C07C45/62 , C07C45/71 , C07C45/73 , C07C45/74 , C07C49/83 , C07C49/835 , C07C49/84 , C07D211/46 , C07D211/52 , C07D295/08 , C07D295/092 , C07D303/22 , C07D303/24 , C07C217/36 , C07C323/25 , C07D207/08 , C07D211/14 , C07D295/088
Abstract: Novel aminopropanol derivatives of 2-hydroxy- beta -phenyl-propiophenones and their physiologically acceptable acid addition compounds, processes for their preparation and therapeutic agents which contain these derivatives and are useful as antiarrhythmic drugs.
-
公开(公告)号:DK161456C
公开(公告)日:1991-12-16
申请号:DK101781
申请日:1981-03-06
Applicant: BASF AG
Inventor: STEINER GERD , HOFMANN HANS PETER , KREISKOTT HORST , TESCHENDORF HANS-JUERGEN , LENKE DIETER
IPC: C07D295/14 , A61K31/275 , A61K31/395 , A61K31/50 , A61K31/55 , A61P25/20 , C07C67/00 , C07C253/00 , C07C255/37 , C07C255/42 , C07D243/08 , C07D295/08 , C07D295/155
Abstract: 10-Substituted 5-cyanomethylene-dibenzo[a,d]-cycloheptenes, their pure cis- and trans-isomers, their N-oxides and their pharmaceutically tolerated addition salts with acids, processes for their preparation, therapeutic agents containing these compounds and their use as drugs, especially as sedatives, hypnotics or tranquilizers.
-
公开(公告)号:DK158979C
公开(公告)日:1991-01-07
申请号:DK566684
申请日:1984-11-29
Applicant: BASF AG
Inventor: FRANKE ALBRECHT , SPIEGLER WOLFGANG , SIEGEL HARDO , MUELLER CLAUS D , PHILIPSBORN GERDA VON , LENKE DIETER , GRIES JOSEF
IPC: A61K31/34 , A61K31/341 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/41 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/495 , A61P9/06 , C07D207/32 , C07D207/333 , C07D213/50 , C07D231/12 , C07D307/46 , C07D333/22 , C07D409/12
-
45.
公开(公告)号:CA1248521A
公开(公告)日:1989-01-10
申请号:CA496920
申请日:1985-12-05
Applicant: FRANKE RENATE , BASF AG
Inventor: FRANKE ALBRECHT , MUELLER CLAUS D , LENKE DIETER
IPC: A61K31/135 , A61K31/13 , A61K31/445 , A61K31/535 , A61K31/5375 , A61P9/06 , C07C67/00 , C07C213/00 , C07C215/38 , C07C217/08 , C07D295/08 , C07D295/084 , C07C91/23 , C07C93/08
Abstract: By reacting a suitable oxirane with a suitable amine, 10,11-dihydro-5H-dibenzo¢a,d!cycloheptadiene derivatives of general formula (I): (I) where R1 is hydrogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-hydroxyalkyl or C1-C4-alkoxy-C1-C4-alkyl and R2 is hydrogen, or R1 and R2, together with the nitrogen atom which connects them to one another, form a morpholine ring or a piperidine ring which may be substituted in the 4position by hydroxyl and/or by unsubstituted or halogensubstituted phenyl, are produced. These substances, and their salts with physiologically tolerated acids, are useful for the treatment of disorders such as in arrhythmias therapy.
-
公开(公告)号:FI77224B
公开(公告)日:1988-10-31
申请号:FI823217
申请日:1982-09-17
Applicant: BASF AG
Inventor: FRANKE ALBRECHT , MUELLER JOSEF , LIETZ HELMUT , WIERSDORFF WALTER-WIELANT , HEGE HANS-GUENTHER , MUELLER CLAUS D , GRIES JOSEF , LENKE DIETER , VON PHILIPSBORN GERDA , RASCHACK MANFRED
IPC: A61K31/13 , A61K31/445 , A61K31/495 , C07C45/62 , C07C45/71 , C07C45/73 , C07C45/74 , C07C49/83 , C07C49/835 , C07C49/84 , C07D211/46 , C07D211/52 , C07D295/08 , C07D295/092 , C07D303/22 , C07D303/24 , C07C93/06 , C07C93/14 , C07C97/10 , C07C149/24 , C07D207/06 , C07D207/12 , C07D211/14 , C07D211/40
Abstract: Novel aminopropanol derivatives of 2-hydroxy- beta -phenyl-propiophenones and their physiologically acceptable acid addition compounds, processes for their preparation and therapeutic agents which contain these derivatives and are useful as antiarrhythmic drugs.
-
公开(公告)号:NO158675B
公开(公告)日:1988-07-11
申请号:NO821083
申请日:1982-03-31
Applicant: BASF AG
Inventor: STEINER GERD , FRIEDRICH LUDWIG , LENKE DIETER
IPC: A61K31/00 , A61K31/55 , A61P1/04 , C07D223/20 , C07D401/06 , C07D401/12 , C07D403/06 , C07D403/12 , C07D413/12 , C07F9/59
-
公开(公告)号:FI75155C
公开(公告)日:1988-05-09
申请号:FI810643
申请日:1981-03-02
Applicant: BASF AG
Inventor: STEINER GERD , HOFMANN HANS PETER , KREISKOTT HORST , TESCHENDORF HANS-JUERGEN , LENKE DIETER
IPC: C07D295/14 , A61K31/275 , A61K31/395 , A61K31/50 , A61K31/55 , A61P25/20 , C07C67/00 , C07C253/00 , C07C255/37 , C07C255/42 , C07D243/08 , C07D295/08 , C07D295/155
-
公开(公告)号:FI74962B
公开(公告)日:1987-12-31
申请号:FI780842
申请日:1978-03-17
Applicant: BASF AG
Inventor: VON PHILIPSBORN GERDA , BOELL WALTER , LENKE DIETER
IPC: A61C8/00 , A61K31/435 , A61K31/44 , A61K31/4406 , A61K31/4415 , A61K31/4418 , A61K31/4427 , A61K31/445 , A61K31/455 , A61K31/495 , A61K31/496 , A61P9/00 , A61P9/04 , A61P9/06 , C07D213/127 , C07D213/65 , C07D213/66 , C07D213/67 , C07D213/79 , C07D213/80 , C07D221/04 , C07D263/32 , C07D401/12 , C07D471/04 , C07D491/04 , C07D491/048 , C07D491/056
Abstract: New pyridinyl aminoalkyl ethers, their N-oxides and their physiologically acceptable addition salts with acids, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful in the treatment of cardiac arrhythmias.
-
公开(公告)号:DK150602C
公开(公告)日:1987-12-07
申请号:DK175179
申请日:1979-04-27
Applicant: BASF AG
Inventor: THIEME PETER C , FRICKEL FRITZ-FRIEDER , THEOBALD HANS , FRANKE ALBRECHT , LENKE DIETER , GRIES JOSEF
Abstract: Alkylamino-propanol derivatives of 3-alkyl-5-(2-hydroxystyryl)-isoxazole, of the general formula where R is hydrogen, alkyl of 1 to 8 carbon atoms, which is unsubstituted or substituted by hydroxyl, alkoxy of 1 to 3 carbon atoms or cycloalkyl with 3 to 8 carbon atoms in the ring, alkenyl or alkynyl of 2 to 8 carbon atoms, or cycloalkyl with 3 to 8 carbon atoms in the ring, the cycloalkyl rings being unsubstituted or mono- or di-substituted by alkyl of 1 to 3 carbon atoms, and R' is alkyl of 1 to 4 carbon atoms, and their addition salts with physiologically acceptable acids, their preparation, and pharmaceutical formulations which contain these compounds and which can be used as valuable drugs in the treatment of hypertonia, coronary diseases of the heart and cardiac arrhythmias.
-
-
-
-
-
-
-
-
-